Change/Insert Date & Location via >Insert >Header & Footer To view drawing guides

Similar documents
Call to action. Dr Anthony Bewley

Brazil Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2018

Spondyloarthropathies: Disease Perception Limits Market

United Kingdom Editors:

Denmark Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2018

Treatment Expectations and Priorities of People with MS

Developments in Psoriasis Management Celgene Corporation 07/14 USII-CELG140030

Diabetes Distress Learning Center

Fatigue after stroke. A patient and carer s guide

2015 U.S. Supplements/OTC/Rx Consumer Research Study

POWERED BY PSO- CLEAR REPORT

Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT. Ipsos SMX. June 2014

United States Editors:

Sample Research Output

Transforming Diabetes Care

Portugal Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2018

EBW. Emotions & Moods Colours Coaching Tool. The EBW Emotional Intelligence System for Business.

What do we mean by Self- Management?

DMEP Study Section 1 1

Spain Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2018

2017 GLOBAL PAIN INDEX (GPI) Better for Everyone

How to Talk to Your Doctor About Psoriatic Arthritis

Psoriasis Disease Severity Affects Patient Satisfaction With Therapy

The Integrative Pain Management Program: A Pilot Clinic Serving High-Risk Primary Care Patients with Chronic Pain

PATIENT SURVEY FOR ADMINISTRATIVE USE ONLY. TO BE COMPLETED BY STUDY COORDINATOR.

Chronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis/Encephalopathy (ME)

The Posi)ve Perspec)ves Study. Simone Marcotullio 22 Se0embre 2017, Roma

LifeStyles Personal Training Attitudinal Assessment (Adapted from the NSCA-CPT attitudinal assessment)

Performance Assessment Network

Clinical Trial Report Synopsis. Patient insights following use of LEO aerosol foam and Daivobet gel in subjects with psoriasis vulgaris

Migraine Report. April Prepared for MSD By StollzNow Research

Anger and Chronic Pain

Joan K. Bardsley RN CDE MBA Medstar Research Institute, Hyattsville MD

Introductory session. Dr Anthony Bewley

Novartis: tackling adherence. ESPACOMP, September, 2010

Improving Type 2 Diabetes Therapy Adherence and Persistence in the United States

ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE

Effective intermittent self- catheterisation training

A SURVEY AMONG PATIENTS AND PHYSICIANS EU THE NETHERLANDS

Pain Management Pathway Redesign. Briefing on Patient Journey Mapping approach to patient interviews

TOBACCO CESSATION SUPPORT PROGRAMME

Greece Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2018

Happiness, Pleasure, and Satisfaction

Russia Editors: LEO Innovation Lab and The Happiness R s esearch Institute Copenhagen, Denmark, October 2018

Perception and insights on fats and fatty acids: knowledge of fat quality of the diet

Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil

Our plan for giving better care to people with dementia Oxleas Dementia

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

Media Contacts: Gina Juliano Rachel St. Martin

keep track of other information like warning discuss with your doctor, and numbers of signs for relapse, things you want to

Finding common ground with people who have diabetes

SAMPLE. 1. Explain how you would carry out an experiment into the effect playing video games has on alertness.

Study Objectives. To understand the influence of socio-economic factors, from a physician viewpoint, regarding the patients :

Evaluating Auditory Contexts and Their Impacts on Hearing Aid Outcomes with Mobile Phones

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

How to: Run Acceptance and Commitment Therapy groups for people with psychosis

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

Injection Impact Survey Executive Summary

Pain Management Programme

Welcome to Motivational Interviewing Enhancing Motivation to Change Strategies. This is the third module that you ll be taking about motivational

ME/CFS : stakeholder engagement meeting. Issues for people with severe ME/CFS

Clinical Trials in Psoriasis

Title of measure: Functional Assessment of Cancer Therapy-Brain (FACT-Br)

Diabetes distress 7 A s model

Hard Edges Scotland: Lived Experience Reference Group

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust

Sanofi Press Breakfast on Behavioral Science. Friday 22 September 2017

ICT4Life. Final Conference. Exploitation : a strategic approach based on iterative testing for real market. Isabella Notarangelo (HOPE)

Living well with and beyond cancer Information, support and practical advice to help you through treatment and beyond

Managing obesity in primary health care Mark Harris

10/9/2015 EMOTIONAL INTELLIGENCE EMOTIONAL INTELLIGENCE

Illness perceptions in patients with chronic kidney disease

A NEW DAWN SHEDS LIGHT ON DIABETES PSYCHOLOGY

European patients perspective on severe asthma symptoms

Patients experiences and perceptions on support to self-manage their long-term condition

Flex:upgrade counsel guide 1.0

Reliability and Validity checks S-005

Breaking Down Barriers and Creating Partnership in Diabetes Self-Management

Cluster 1 Common Mental Health Problems (mild)

The Self Care: Be Your Best Report A global study on common health conditions and how people practice self care

Mental and Behavioral Health Needs Assessment CONSUMER SURVEY

Emotional Intelligence

The Potential Psychological Impact of Skin Conditions

CBT+ Measures Cheat Sheet

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Substance Use Risk 5: Drugs, Alcohol, and HIV

Evaluation of ProReal-Based Therapy within a Prison Setting

Overcome anxiety & fear of uncertainty

ARTHRITIS ACTION FACTSHEETS

MEN S HEALTH PERCEPTIONS FROM AROUND THE GLOBE

active lives adult survey understanding behaviour Published February 2019

THE POTENTIAL FOR QUALITATIVE METHODS TO ENHANCE HEALTH SERVICES AND OUTCOMES RESEARCH: WHY, WHEN AND HOW?

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

FACILITATOR GUIDE: Promoting Adherence and Health Behavior Change DocCom Module 16

Patient Engagement: The Dilemma of Poor Adherence to Blood Pressure Medications

Spinal Cord Injury Research. By the Department of Clinical Psychology, National Spinal Injuries Centre

Your Child Deal With Depression

Hope for a better life. And the help and support to get you there.

Connecting the Community. Advancing the HIV Response in Baltimore and Jackson.

Representations and Adjustment Index (RADIX) Catherine Quinn, Robin Morris and Linda Clare

Two Takes on Fibro: Public Perceptions and Private Realities

Transcription:

Patient profiling

Who is your patient and what do they want to hear? What are your patient s ideas, concerns, expectations (ICE)? How much do they already know about their psoriasis? Is your patient more concerned about appearance, itching or the inconvenience of applying treatments? What do they expect from their treatment and are they likely to adhere to the treatment regimen? Given limited consultation time, being able to profile your patient should improve the quality of consultations as well as making that time more effective Understanding that your patient s profile may change over time will enable you to tailor their management accordingly

Large, multinational study to help understand different patient types who might benefit from individualised interventions Countries participating in the study Identifying patients who are in need of additional support

Research insights: study design Stage 1 Qualitative Stage 1 Qualitative Ethnographic study of 56 patients with psoriasis 42 respondents studied for 1 day 14 respondents studied for 2 days Countries: UK, France, Germany, Italy, Spain, USA, Canada Stage 2 Quantitative Qualitative stage guided development of the quantitative questionnaire and sample Online methodology, 40 minutes 3822 patients with psoriasis* Markets: Patient criteria 18 years old or over Suffer from psoriasis and/or psoriatic arthritis UK FR DE ES IT US CA Tot 608 571 488 577 358 609 611 3822 *Includes the 1884 patients currently using prescription treatments for psoriasis that are reported in Bewley et al. J Eur Acad Dermatol Venereol 2014;28:763 770

Robust methodology for generating a patient profile Phase 1: Burden of psoriasis studies Capture of patient data via interviews, course-of-day exercises, photo diaries and field notes Link between medical and psychological well-being Channels of influence, variations in perception of treatment Large amounts of raw ethnographic data Data processing, analysis and synthesis Understanding of the relationship between burden of disease and burden of treatment: parameters for patient classification Quantitative validation and ranking of data Quantification of core emotional drivers/patient segments, understanding of patient relationship with treatment and HCPs

Robust methodology for generating a patient profile Phase 2: Patient profiles Integration of data from burden of psoriasis studies, data from other patient panels and groups, and social media listening Data clustered based on patients needs and preferences Identification of patterns for profiles that represent poles within population of psoriasis patients Consolidation of the profiles: establishing clear delineations with respect to burden of disease and treatment Validation of the profiles with GPs and dermatologists

Profiles are based on key intrinsic, behavioural and attitudinal characteristics Intrinsic characteristics Patient history with psoriasis Burden of disease/treatment scores Differentiating behaviours Treatment choice Frequency of HCP visits QoL impact Differentiating attitudes Satisfaction with current medication Receptivity to new treatments Trust in HCPs

Research insights: understanding patients Engagement with treatment High Self-manager 40% Why me? 28% Actively engaged 16% Help me 16% Low Low High Burden of disease

NEGATIVE EXPERIENCE POSITIVE EXPERIENCE The four segments all have distinct problems with prescription topicals Self-manager Irregular treatment (mix and match/fire fighting) caused by a fear of side effects and an unmet need for more specific treatments I know cortisone creams help but I use them only sometimes. Actively engaged The burden of treatment is high (time, yuckiness), but due to satisfaction with efficacy, PTs are used compliantly I must improve my condition, so compliance is essential. Among PTs, there are not enough choices LOW DISEASE IMPACT PTs are still a compromise HIGH DISEASE IMPACT Why me? Dropped out after a frustrating experience of trial-and-error with PTs There are no creams that help, so why bother then? Help me Deep disappointment with efficacy of PTs, therefore not considering them as proper medical treatment Creams are creams, a waste of time I want real medicine. Given up on PTs and the HCS Overall low involvement with medicine HCS, healthcare system; PT, psoriasis treatments

Four patient profiles developed 40% 16% Self-manager Actively engaged 28% 16% Why me? Help me

NEGATIVE EXPERIENCE POSITIVE EXPERIENCE We identified different means to increase the segments satisfaction with prescription topical efficacy Self-managers require Focused treatments with short-term results Treatments that live up to their fear of side effects (especially their reluctance towards steroids) Products specialised in reducing visibility Actively engaged require Further improved PT products (regarding efficacy and burden of treatment) A treatment more sustainable than systemics A treatment that can usefully complement systemics from the outside (skin) LOW DISEASE IMPACT HIGH DISEASE IMPACT Why me? require Effective and low burden medical treatments A better and less confusing understanding of psoriasis An environment that understands and cares about their psoriasis Help me require Conviction that products have real medical value A systemised treatment regimen Clearer instructions and increased care from the HCS New hope

Profile: Self-manager Self-manager 40% Tend to have the most positive outlook on life Psoriasis has least impact on quality of life Not as likely to be current users of prescription medicine; would avoid using treatments unless necessary Least receptive to new treatments Refer to psoriasis information least frequently 72% have mild psoriasis

Profile: Why me? Why me? 28% Psoriasis not as severe as Help me group; however, not coping that well with psoriasis 50% use prescription medicine; 33% use non-prescription medicine Not as satisfied with topicals; would try to avoid prescription medicine unless necessary Least trusting of their HCPs Least adherent segment (41%) 53% have moderate psoriasis; 35% mild

Profile: Help me Help me 16% Tend to have the most negative outlook Highest percentage of body affected by psoriasis Psoriasis has highest impact on quality of life Tend not to have a good relationship with their HCP Most receptive to new treatments Refer to psoriasis information the most frequently 57% have moderate psoriasis; 32% severe

Profile: Actively engaged Actively engaged 16% 40% use prescription medicine and 40% use non-prescription medicine Have the most positive relationship with their HCP Tend to trust their HCP the most Tend to have a good level of satisfaction of topicals The most adherent segment (54%) 56% have moderate psoriasis; 33% mild

Interactive session PROFILING YOUR PATIENTS Refer to handout

Answer key questions about your patient to assist in profiling Burden of disease Engagement with treatment Why me? Self-manager Help me Actively engaged

Questions about burden of disease Psoriasis disease impact Psoriasis stops you from doing everyday tasks You feel unhappy about your skin Your psoriasis affects your relationships with people Your psoriasis affects your sleep patterns Your psoriasis affects your confidence Your psoriasis stops you from socialising, going out or playing sports Your psoriasis flares Your psoriasis is itchy OVERALL your psoriasis affects your quality of life

Questions about engagement with treatment Patient s engagement with treatment Your treatment makes a difference to your skin You like your treatments You follow the treatment regime recommended to you by your HCP Your lifestyle doesn t interfere with your regime Treatment really works for your psoriasis You understand how using your treatment helps you You like going to see your doctor/nurse/hcp You have time to use your treatments OVERALL you are satisfied and engaged with your treatment plan

Plot where your patient scores on the two axes Engaged with treatment Agree Agree a bit Disagree a bit Disagree Burden of disease Plot your scores on the graphs provided and try to identify which patient group or profile best fits the description of your patient

Plot where your patient scores on the two axes Engaged with treatment Agree Self-manager Actively engaged Agree a bit Disagree a bit Why me Help me! Disagree Burden of disease Plot your scores on the graphs provided and try to identify which patient group or profile best fits the description of your patient

Plot where your patient scores on the two axes Engaged with treatment Agree Agree a bit Disagree a bit Disagree Burden of disease For example, this patient is highly engaged with treatment, with occasional disease burden

Plot where your patient scores on the two axes Engaged with treatment Agree Self-manager Actively engaged Agree a bit Disagree a bit Why me Help me! Disagree Burden of disease it is likely that they are in the self-manager category

Plot where your patient scores on the two axes Engaged with treatment Agree Self-manager Actively engaged Agree a bit Disagree a bit Why me Help me! Disagree Burden of disease Plot your scores on the graphs provided and try to identify which patient group or profile best fits the description of your patient

19 November 2015 p. 026 DELETED SLIDES

Questions about burden of disease Scoring Never = 0 Occasionally = 1 Often = 2 A lot = 3 Psoriasis disease impact Psoriasis stops you from doing everyday tasks You feel unhappy about your skin Your psoriasis affects your relationships with people Your psoriasis stops you from doing the things you like to do Your psoriasis affects your confidence Your psoriasis stops you from socialising, going out or playing sports Your psoriasis flares Your psoriasis is itchy Total out of 24

Questions about engagement with treatment Patient s engagement with treatment Range 1. My treatment makes a difference to my skin 0 1 2 3 2. I like my treatments 0 1 2 3 Scoring 0 = disagree 1 = disagree a bit 2 = agree a bit 3 = agree 3. I follow the treatment regime recommended to me by my HCP 0 1 2 3 4. My lifestyle doesn t interfere with my regime 0 1 2 3 5. Treatment really works for my psoriasis 0 1 2 3 6. I understand how using my treatment helps me 0 1 2 3 7. I like going to see my doctor/nurse/hcp 0 1 2 3 8. I have time to use my treatments 0 1 2 3 Total out of 24

Assign patient profiles using disease impact and engagement scores Disease burden 0 12 Engagement with treatment 0 12 Why me? 0 12 13 24 Selfmanager 13 24 0 12 Help me 13 24 13 24 Actively engaged

Plot where you think your patient scores to the question Engagement with treatment 24 Self-manager 40% Actively engaged 16% Why me 28% Help me! 16% 0 0 24 Burden of disease Plot your scores on the graphs provided and try to identify which patient group or profile best fits the description of your patient